International experiences of promoting generics use and its implications to China.
about
Prescribing efficiency of proton pump inhibitors in China: influence and future directionsPolicy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries.Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history.Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction.How much could be saved in Chinese hospitals in procurement of anti-hypertensives and anti-diabetics?
P2860
International experiences of promoting generics use and its implications to China.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
International experiences of promoting generics use and its implications to China.
@en
International experiences of promoting generics use and its implications to China.
@nl
type
label
International experiences of promoting generics use and its implications to China.
@en
International experiences of promoting generics use and its implications to China.
@nl
prefLabel
International experiences of promoting generics use and its implications to China.
@en
International experiences of promoting generics use and its implications to China.
@nl
P2860
P356
P1476
International experiences of promoting generics use and its implications to China.
@en
P2093
P2860
P356
10.1111/JEBM.12030
P577
2013-05-01T00:00:00Z